# Yantai Projiji Pharmaceutical expands recombinant human albumin capacity

Yantai Projimed Pharmaceutical Technology Co., Ltd. announced an expansion project for recombinant human albumin production in Yantai, Shandong. The 1 billion yuan investment will add production lines, increasing annual capacity to 1.7 million vials.

- Type: Expansion
- Announced: 2025-04-28
- Where: Yantai, Shandong, China
- Value: $138.0M (1.00B CNY)
- Status: announced
- Capacity: 1.7 million vials of recombinant human albumin per year
- Products: recombinant human albumin
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Yantai Projimed Pharmaceutical Technology](https://endata.com/companies/84397.md)

## Sources

- [en.protgen.com](http://en.protgen.com/news_details/1916785878958411776.html), 2025-04-28: "Total Project Investment 100000 Ten thousand yuan, industry category is C2761 Biopharmaceutical manufacturing."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.